Biopharmaceutical Market Directions: The Next Decade in Plasmapheresis Treatment

As biopharmaceutical manufacturers move to increase their supply of all types of biotechnology products in the face of consistent domestic demand and growing offshore markets, one treatment is emerging as a global leader with significant growth potential.

A recent report predicts that the demand for plasmapheresis will grow 7%, compounded annually, over the next several years, reaching a total of $1.5 billion by the end of 2026. With such staggering growth comes an investment opportunity that few biopharmaceutical companies in the U.S. market are currently prepared to handle.

CfPIE’s two-day Biopharmaceutical Development Certified Professional™ program focuses on the spectrum of existing and new biopharmaceuticals, detailing what professionals in this area need to know to guide their companies through the development process. You can design your course list specifically for your needs, including classes on CMC regulatory compliance, process validation and product quality reviews. The full scope of the development process from conception to market is taught by our expert instructors with real-world, hands-on experience.

This professional development course will help you lead your biopharmaceutical company into the future and capture some of the market share in a growing business. It is estimated that, in the plasmapheresis market alone, disposables or single-use products are likely to surpass traditional instruments in the next decade. This relatively new biotechnology has significant potential across a range of products. Will your company be a real player in the disposables market? The right training can put you out front as a business, or as an in-demand professional in this industry.

To learn more about our biopharmaceutical course offerings, click here.

Sources:

https://www.factmr.com/report/351/plasmapheresis-market

https://www.factmr.com/media-release/340/plasmapheresis-market